nach oben

Current Anesthesiology Reports

Erschienen in:

01.06.2018 | Neuromuscular Blockade (GS Murphy, Section Editor)

Neuromuscular Blocking Drugs and Postoperative Pulmonary Complications

verfasst von: Letha Mathews, Jesse M. Ehrenfeld

Erschienen in: Current Anesthesiology Reports | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The purpose of this chapter is to provide a brief review of the literature around the relationship between the use of neuromuscular blocking drugs and subsequent postoperative pulmonary complications.

Recent Findings

A recent series of retrospective studies evaluating the use of neuromuscular blocking agents and postoperative complications have demonstrated growing evidence for a clear relationship between the use of the agents and downstream complications. The frequency of postoperative respiratory problems seems to be mitigated to some degree through the appropriate use of reversal agents.

Summary

Care should be exercised when administering neuromuscular blocking agents during surgical procedures. Appropriate monitoring of neuromuscular transmission should be used along with a strategy to provide adequate reversal at the end of the surgical procedure.

Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008;372(9633):139–44. https://doi.org/10.1016/S0140-6736(08)60878-8.CrossRefPubMed

O’Leary ME, Filatov GN, White MM. Characterization of d-tubocurarine binding site of Torpedo acetylcholine receptor. Am J Phys. 1994;266(3 Pt 1):C648–53. https://doi.org/10.1152/ajpcell.1994.266.3.C648.CrossRef

McIntyre AR, King RE. Contraction of denervated muscle produced by d-tubocurarine. Science. 1943;97(2527):516. https://doi.org/10.1126/science.97.2527.516.CrossRefPubMed

Daly HJ, Marshall SV. Curare in anaesthesia; a preliminary note. Med J Aust. 1946;2:14–6.CrossRefPubMed

Bourne JG. Long action of suxamethonium (succinylcholine) chloride. Br J Anaesth. 1953;25(2):116–29.CrossRefPubMed

Hund HC, Rice MJ, Ehrenfeld J. An evaluation of the state of neuromuscular blockade monitoring devices. J Med Syst. 2016;40(12):281. https://doi.org/10.1007/s10916-016-0641-z.CrossRefPubMed

Ali HH, Savarese JJ. Stimulus frequency and dose-respone curve to d-tubocurarine in man. Anesthesiology. 1980;52(1):36–9.CrossRefPubMed

Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98(5):1042–8.CrossRefPubMed

Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth. 2007;98(3):302–16. https://doi.org/10.1093/bja/ael386.CrossRefPubMed

10.

Stawicki N, Gessner P. Residual neuromuscular blockade in the critical care setting. AACN Adv Crit Care. 2018;29(1):15–24. https://doi.org/10.4037/aacnacc2018384.CrossRefPubMed

11.

• Belcher AW, Leung S, Cohen B, Yang D, Mascha EJ, Turan A, et al. Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005–2013: a single center study. J Clin Anesth. 2017;43:33–8. https://doi.org/10.1016/j.jclinane.2017.09.005. Published in 2013, a large study of 128,886 patients who had received a neuromuscular blocking agent between April 2005 and December 2013. CrossRefPubMed

12.

• Bronsert MR, Henderson WG, Monk TG, Richman JS, Nguyen JD, Sum-Ping JT, et al. Intermediate-acting nondepolarizing neuromuscular blocking agents and risk of postoperative 30-day morbidity and mortality, and long-term survival. Anesth Analg. 2017;124(5):1476–83. https://doi.org/10.1213/ANE.0000000000001848. Published in 2017, a study of respiratory complications after neuromuscular blockade in 11,355 Veteran Affair Health System patients. CrossRefPubMed

13.

•• Bulka CM, Terekhov MA, Martin BJ, Dmochowski RR, Hayes RM, Ehrenfeld JM. Nondepolarizing neuromuscular blocking agents, reversal, and risk of postoperative pneumonia. Anesthesiology. 2016;125(4):647–55. https://doi.org/10.1097/ALN.0000000000001279. Published in 2016, this study of 13,100 surgical cases compared surgical patients who received reversal with neostigmine to patients who did not and found that nonreversal was associated with an increased risk of postoperative pneumonia. CrossRefPubMed

14.

• Martinez-Ubieto J, Ortega-Lucea S, Pascual-Bellosta A, Arazo-Iglesias I, Gil-Bona J, Jimenez-Bernardo T, et al. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex. Minerva Anestesiol. 2016;82(7):735–42. Published in 2016, this prospective study of 558 patients evaluated residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex. PubMed

15.

Brull SJ, Kopman AF. Current status of neuromuscular reversal and monitoring: challenges and opportunities. Anesthesiology. 2017;126(1):173–90. https://doi.org/10.1097/ALN.0000000000001409.CrossRefPubMed

16.

Ledowski T, Falke L, Johnston F, Gillies E, Greenaway M, De Mel A, et al. Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: sugammadex, neostigmine or no reversal. Eur J Anaesthesiol. 2014;31(8):423–9. https://doi.org/10.1097/EJA.0000000000000010.CrossRefPubMed

17.

Todd MM, Hindman BJ, King BJ. The implementation of quantitative electromyographic neuromuscular monitoring in an academic anesthesia department. Anesth Analg. 2014;119(2):323–31. https://doi.org/10.1213/ANE.0000000000000261.CrossRefPubMed

18.

Thomsen JLD, Mathiesen O, Hagi-Pedersen D, Skovgaard LT, Ostergaard D, Engbaek J, et al. Improving neuromuscular monitoring and reducing residual neuromuscular blockade with E-learning: protocol for the multicenter interrupted time series INVERT study. JMIR Res Protoc. 2017;6(10):e192. https://doi.org/10.2196/resprot.7527.CrossRefPubMedPubMedCentral

Titel: Neuromuscular Blocking Drugs and Postoperative Pulmonary Complications
verfasst von: Letha Mathews
Jesse M. Ehrenfeld
Publikationsdatum: 01.06.2018
Verlag: Springer US
Erschienen in: Current Anesthesiology Reports / Ausgabe 2/2018
Elektronische ISSN: 2167-6275
DOI: https://doi.org/10.1007/s40140-018-0272-7

Neu im Fachgebiet AINS

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Neuromuscular Blocking Drugs and Postoperative Pulmonary Complications

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet AINS

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Hochrisiko-Eingriffe für postoperative Übelkeit

Diclofenac-Gel versus Ibuprofen bei akuten Rückenschmerzen

Update AINS

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

Perioperative Outcome in Geriatric Patients

Sugammadex: Appropriate Use in the Context of Budgetary Constraints

Mivacurium: a Review

Liver Transplantation: Perioperative Care and Update on Intraoperative Management

Neostigmine: Mechanism of Action, Dosing, and Factors Determining Adequacy of Recovery Following Administration

Profound Neuromuscular Blockade: Advantages and Challenges for Patients, Anesthesiologists, and Surgeons

Neu im Fachgebiet AINS

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Hochrisiko-Eingriffe für postoperative Übelkeit

Diclofenac-Gel versus Ibuprofen bei akuten Rückenschmerzen

Update AINS